Sildenafil Citrate/Clomipramine Hydrochloride

Tier C — Watch / trade

Ctc Bio America Inc

Originator

2024

First approval

Expiry (public)

No sales data

Peak sales

Small molecule

Type

Targets：NET, PDE5A, SERT

Indications (approved)：Premature ejaculation

Regional status

China

Japan

Factories producing this API9

Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.

9 producing factories on file — sign in to view the named list (factory details are not shown to guests).

Synthetic routes & intermediates

Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.

Frequently asked questions

What are the approved indications of Sildenafil Citrate/Clomipramine Hydrochloride?

Approved indications include: Premature ejaculation.

When does the Sildenafil Citrate/Clomipramine Hydrochloride patent expire?

No public expiry year is available for Sildenafil Citrate/Clomipramine Hydrochloride yet; this page updates once verified.

How do I get a quote for Sildenafil Citrate/Clomipramine Hydrochloride intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-27